Page last updated: 2024-12-05

hexamethylbenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hexamethylbenzene is a highly symmetrical aromatic hydrocarbon with six methyl groups attached to a benzene ring. It is a white crystalline solid at room temperature. Its synthesis typically involves the methylation of benzene or other aromatic compounds using Friedel-Crafts alkylation. Hexamethylbenzene is a useful reagent in organic synthesis and is also studied for its physical properties, such as its high melting point and its ability to form stable complexes with electron acceptors. Research on this compound explores its potential applications in materials science and in the development of new organic electronic devices.'

hexamethylbenzene : A methylbenzene that is benzene in which all six hydrogens have been replaced by methyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6908
CHEMBL ID16347
CHEBI ID39001
MeSH IDM0242197

Synonyms (41)

Synonym
4342-40-9
AKOS015842251
wln: 1r b1 c1 d1 e1 f1
87-85-4
mellitene
benzene, hexamethyl-
hexamethylbenzene
nsc-3838
nsc3838
1,2,3,4,5,6-hexamethyl-benzene
nsc 3838
ai3-03275
einecs 201-777-0
inchi=1/c12h18/c1-7-8(2)10(4)12(6)11(5)9(7)3/h1-6h
benzene,hexamethyl
hexamethylbenzene, purified by sublimation, >=99%
hexamethylbenzene, 99%
1,2,3,4,5,6-hexamethylbenzene
CHEBI:39001 ,
hexamethylbenzol
CHEMBL16347
H0087
H0410
A842388
j8sd5741v8 ,
benzene, 1,2,3,4,5,6-hexamethyl-
unii-j8sd5741v8
FT-0627016
hexamethyl benzene
DTXSID3058957
1,2,3,4,5,6-hexamethylbenzene #
mfcd00008523
Q413592
2,4-imidazolidinedione, 1-propyl-
Z276588070
hexamethylbenzene zone refined (number of passes:20)
D87567
AS-81609
CS-0095851
EN300-139722
SY012954
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
methylbenzeneAny alkylbenzene that is benzene substituted with one or more methyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.88)18.7374
1990's1 (5.88)18.2507
2000's7 (41.18)29.6817
2010's7 (41.18)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.18 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index57.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]